Differential regional gene expression from cardiac dyssynchrony induced by chronic right ventricular free wall pacing in the mouse

Physiological Genomics

Volumn 26, Issue 2, 2006, Pages 109-115

  Bilchick, Kenneth C ^a   Saha, Sudip K ^a   Mikolajczyk, Ed ^c   Cope, Leslie ^b   Ferguson, Will J ^d   Yu, Wayne ^b   Girouard, Steven ^c   Kass, David A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c BOSTON SCIENTIFIC CORPORATION   (United States)

^d Agilent Technologies   (United States)

Author keywords

Activation timing; Heart; Microarray

Indexed keywords

LITHIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTIFICIAL HEART PACEMAKER; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; DOPPLER FLOWMETRY; DYE DILUTION CURVE; ELECTRIC BATTERY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART MUSCLE; HEART PACING; HEART RIGHT VENTRICLE; HEART VENTRICLE SEPTUM; IATROGENIC DISEASE; MICROARRAY ANALYSIS; MOUSE; MUSCLE CELL; MUSCLE CONTRACTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PURKINJE CELL; QUANTITATIVE ANALYSIS; SINUS NODE; STEM CELL; STRESS;

ANIMALS; CARDIAC PACING, ARTIFICIAL; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART VENTRICLES; MICE; MICE, INBRED C57BL; MODELS, STATISTICAL; MYOCARDIUM; PACEMAKER, ARTIFICIAL; POLYMERASE CHAIN REACTION;

MURINAE;

EID: 33745945865     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00281.2005     Document Type: Article

References (29)

1. Alyonycheva T, Cohen-Gould L, Siewert C, Fischman DA, and Mikawa T. Skeletal muscle-specific myosin binding protein-H is expressed in Purkinje fibers of the cardiac conduction system. Circ Res 80: 665-672, 1997.
2. Baldasseroni S, De Biase L, Fresco C, Marchionni N, Marini M, Masotti G, Orsini G, Porcu M, Pozzar F, Scherillo M, and Maggioni AP. Cumulative effect of complete left bundle-branch block and chronic atrial fibrillation on 1-year mortality and hospitalization in patients with congestive heart failure. A report from the Italian network on congestive heart failure (in-CHF database). Eur Heart J 23: 1692-1698, 2002.
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, and Feldman AM. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350: 2140-2150, 2004.
4. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, and Tavazzi L. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352: 1539-1549, 2005.
5. Dyson E, Sucov HM, Kubalak SW, Schmid-Schonbein GW, DeLano FA, Evans RM, Ross J Jr, and Chien KR. Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha-/- mice. Proc Natl Acad Sci USA 92: 7386-7390, 1995.
6. Flashman E, Redwood C, Moolman-Smook J, and Watkins H. Cardiac myosin binding protein C: its role in physiology and disease. Circ Res 94: 1279-1289, 2004.
7. Georgakopoulos D and Kass D. Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart. J Physiol 534: 535-545, 2001.
8. Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, Marboe CC, Fleck E, and Hsueh WA. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 96: 3063-3071, 1997.
9. Gregory CA, Singh H, Perry AS, and Prockop DJ. The Wnt signaling inhibitor dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J Biol Chem 278: 28067-28078, 2003.
10. Horwitz EM. Dkk-1-mediated expansion of adult stem cells. Trends Biotechnol 22: 386-388, 2004.
11. Khalina YN, Bartsch H, Petzhold D, Haase H, Podlubnaya ZA, Shpagina MD, and Morano I. Reconstitution of ventricular myosin with atrial light chains-1 improves its functional properties. Acta Biochim Pol 2005.
12. Monaghan AP, Kioschis P, Wu W, Zuniga A, Bock D, Poustka A, Delius H, and Niehrs C. Dickkopf genes are co-ordinately expressed in mesodermal lineages. Mech Dev 87: 45-56, 1999.
13. Paulsson M and Heinegard D. Matrix proteins bound to associatively prepared proteoglycans from bovine cartilage. Biochem J 183: 539-545, 1979.
14. Ritter O, Luther HP, Haase H, Baltas LG, Baumann G, Schulte HD, and Morano I. Expression of atrial myosin light chains but not alpha-myosin heavy chains is correlated in vivo with increased ventricular function in patients with hypertrophic obstructive cardiomyopathy. J Mol Med 77: 677-685, 1999.
15. Saharinen J, Hyytiainen M, Taipale J, and Keski-Oja J. Latent transforming growth factor-beta binding proteins (LTBPs)-structural extracellular matrix proteins for targeting TGF-beta action. Cytokine Growth Factor Rev 10: 99-117, 1999.
16. Schellings MW, Pinto YM, and Heymans S. Matricellular proteins in the heart: possible role during stress and remodeling. Cardiovasc Res 64: 24-31, 2004.
17. Segat D, Frie C, Nitsche PD, Klatt AR, Piecha D, Korpos E, Deak F, Wagener R, Paulsson M, and Smyth N. Expression of matrilin-1, -2 and -3 in developing mouse limbs and heart. Matrix Biol 19: 649-655, 2000.
18. Small EM and Krieg PA. Molecular regulation of cardiac chamber-specific gene expression. Trends Cardiovasc Med 14: 13-18, 2004.
19. Spragg DD, Akar FG, Helm RH, Tunin RS, Tomaselli GF, and Kass DA. Abnormal conduction and repolarization in late-activated myocardium of dyssynchronously contracting hearts. Cardiovasc Res 67: 77-86, 2005.
20. Spragg DD, Leclercq C, Loghmani M, Faris OP, Tunin RS, DiSilvestre D, McVeigh ER, Tomaselli GF, and Kass DA. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation 108: 929-932, 2003.
21. Stoughton R and Dai H. USPTO Patent Full-Text and Image Database. Statistical Combining of Cell Expression Profiles. US Patent No. 6351712 (online). http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2= HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f= G&l=50&s1=6351712.PN.&OS=PN/6351712&RS=PN/6351712 [22 May 2006].
22. Strom A, Franzen A, Wangnerud C, Knutsson AK, Heinegard D, and Hultgardh-Nilsson A. Altered vascular remodeling in osteopontin-deficient atherosclerotic mice. J Vasc Res 41: 314-322, 2004.
23. Sutsch G, Brunner UT, von Schulthess C, Hirzel HO, Hess OM, Turina M, Krayenbuehl HP, and Schaub MC. Hemodynamic performance and myosin light chain-1 expression of the hypertrophied left ventricle in aortic valve disease before and after valve replacement. Circ Res 70: 1035-1043, 1992.
24. Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S, Liaw L, Jenkins AW, Wang J, Sawyer DB, Bing OH, Apstein CS, Colucci WS, and Singh K. Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 88: 1080-1087, 2001.
25. Tusher VG, Tibshirani R, and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
26. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, and Sharma A. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288: 3115-3123, 2002.
27. Xie Z, Singh M, and Singh K. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice. Hypertension 44: 826-831, 2004.
28. Zhang G, He B, and Weber GF. Growth factor signaling induces metastasis genes in transformed cells: molecular connection between Akt kinase and osteopontin in breast cancer. Mol Cell Biol 23: 6507-6519, 2003.
29. Zohar R, Zhu B, Liu P, Sodek J, and McCulloch CA. Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway. Am J Physiol Heart Circ Physiol 287: H1730-H1739, 2004.